[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $2374b Johnson & Johnson (JNJ) shares are up after a strong Q2 earnings report, beating estimates and raising the company's outlook for the year. The stock is up X% after Q2 results beat estimates. ### About $2374b This topic is about the financial performance and social media discussion surrounding Johnson & Johnson (JNJ) stock. ### Insights [#](/topic/$2374b/insights) - $2374b Creators hit a high of XX for the day - $2374b Creators hit an all time of XX for the day - $2374b Mentions hit a high of XX for the day - $2374b Mentions hit an all time of XX for the day - $2374b Sentiment hit an all time of XXX for the day - $2374b Engagements hit a high of XXXXXX for the day - $2374b Engagements hit an all time of XXXXXX for the day ### Engagements: XXX [#](/topic/$2374b/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$2374b/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XXXXX **6 Months**: XXXXXX +7,632% **1 Year**: XXXXXX -XX% **1-Year High**: XXXXXX on 2025-07-16 **1-Year Low**: X on 2024-10-22 | Social Network | X | | -------------- | - | | Engagements | XXX | ### Mentions: XX [#](/topic/$2374b/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$2374b/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: X **6 Months**: XX +313% **1 Year**: XX +273% **1-Year High**: XX on 2025-07-17 **1-Year Low**: X on 2024-10-05 | Social Network | X | | -------------- | - | | Mentions | XX | ### Creators: XX [#](/topic/$2374b/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$2374b/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning $2374b in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: X **6 Months**: XX +314% **1 Year**: XX +260% **1-Year High**: XX on 2025-07-17 **1-Year Low**: X on 2024-10-05 ### Sentiment: XXX% [#](/topic/$2374b/sentiment) ---  [Sentiment 24-Hour Chart Data](/topic/$2374b/time-series/sentiment.tsv) **Current Value**: XXX% **Daily Average**: XXX% **1 Year**: XXX% +93% **1-Year High**: XXX% on 2025-07-16 **1-Year Low**: XXX% on 2025-07-16 **Most Supportive Themes** - **Positive Earnings Report for JNJ:** (80%) Johnson & Johnson (JNJ) reported strong Q2 earnings, exceeding revenue and EPS estimates, leading to positive sentiment and increased stock price. - **Market Outperformance:** (20%) The market is reacting positively to Johnson & Johnson's (JNJ) strong performance, with analysts and investors highlighting the company's robust revenue and earnings. **Most Critical Themes** Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXX | XX% | XXX | XX% | X | X% | | | | | | | | | | Total | XXX | XX% | XXX | XX% | X | X% | **Top assets mentioned** In the posts about $2374b in the last XX hours [Johnson & Johnson (JNJ)](/topic/$jnj) [Johnson & Johnson (JNJ)](/topic/johnson-johnson) [Innovative Solutions & Support (ISSC)](/topic/$issc) [Basis Cash (BAC)](/topic/$bac) [Bank of America (BAC)](/topic/bank-of-america) [GammaSwap (GS)](/topic/$gs) [Morgan Stanley (MS)](/topic/$ms) [Morgan Stanley (MS)](/topic/morgan-stanley) [Goldman Sachs (GS)](/topic/goldman-sachs) [Ventas, Inc. (VTR)](/topic/$vtr) **Top topics mentioned** In the posts about $2374b in the last XX hours [eps](/topic/eps), [jnj](/topic/jnj), [$jnj](/topic/$jnj), [johnson johnson](/topic/johnson-johnson), [stocks healthcare](/topic/stocks-healthcare), [$2286b](/topic/$2286b), [rev](/topic/rev), [$932b](/topic/$932b), [medtech](/topic/medtech), [$936b](/topic/$936b), [$2285b](/topic/$2285b), [$913b](/topic/$913b), [$issc](/topic/$issc), [$2284b](/topic/$2284b), [stocks](/topic/stocks), [$554b](/topic/$554b), [$2283b](/topic/$2283b), [$914b](/topic/$914b), [$934b](/topic/$934b), [med](/topic/med), [$354b](/topic/$354b), [$bac](/topic/$bac), [bank of america](/topic/bank-of-america), [stocks financial services](/topic/stocks-financial-services), [stocks banks](/topic/stocks-banks), [del](/topic/del), [$62b](/topic/$62b), [$931b](/topic/$931b), [$927b](/topic/$927b), [quarterly earnings](/topic/quarterly-earnings), [cmg](/topic/cmg), [$338b](/topic/$338b), [$181b](/topic/$181b), [$165b](/topic/$165b), [$1350b](/topic/$1350b), [$1458b](/topic/$1458b), [$gs](/topic/$gs), [$1591b](/topic/$1591b), [$168b](/topic/$168b), [$ms](/topic/$ms), [$2659b](/topic/$2659b), [$265b](/topic/$265b), [united states](/topic/united-states), [bank of](/topic/bank-of), [$2280b](/topic/$2280b), [notable](/topic/notable), [morgan stanley](/topic/morgan-stanley), [goldman sachs](/topic/goldman-sachs), [wallstreet](/topic/wallstreet), [new york stock exchange](/topic/new-york-stock-exchange), [investment](/topic/investment), [$vtr](/topic/$vtr), [stocks real estate](/topic/stocks-real-estate), [coins ai](/topic/coins-ai), [dru](/topic/dru), [cash flow](/topic/cash-flow), [$918b](/topic/$918b), [$91b](/topic/$91b), [open ai](/topic/open-ai), [$amd](/topic/$amd), [athens](/topic/athens), [advanced micro devices](/topic/advanced-micro-devices), [stocks technology](/topic/stocks-technology), [coins defi](/topic/coins-defi), [bmnr](/topic/bmnr), [founders fund](/topic/founders-fund), [bitmine](/topic/bitmine), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$bmnr](/topic/$bmnr), [stockmarket](/topic/stockmarket), [$85b](/topic/$85b), [sales forecast](/topic/sales-forecast), [$838b](/topic/$838b), [$1846b](/topic/$1846b), [$1555b](/topic/$1555b), [bitfinex](/topic/bitfinex), [$4141b](/topic/$4141b), [$2549b](/topic/$2549b), [$2394b](/topic/$2394b), [$3157b](/topic/$3157b), [$2195b](/topic/$2195b), [bitcoin](/topic/bitcoin), [coins layer 1](/topic/coins-layer-1), [coins bitcoin ecosystem](/topic/coins-bitcoin-ecosystem), [coins pow](/topic/coins-pow), [$fbtc](/topic/$fbtc), [stocks etf](/topic/stocks-etf), [stocks bitcoin spot etf](/topic/stocks-bitcoin-spot-etf), [stocks crypto etfs](/topic/stocks-crypto-etfs), [ticker](/topic/ticker), [tax bracket](/topic/tax-bracket) ### Top Social Posts [#](/topic/$2374b/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Grayscale (Grayscale Bitcoin Trust): $21.95B$31.57B (183349263801 BTC) U.S. Government: $23.94B$25.49B (200000213000 BTC) Fidelity (FBTC): $23.74B$41.41B (198424346000 BTC) Bitfinex: $15.55B$18.46B (130010154246 BTC) Winklevoss Twins: $8.38B (70000 BTC)" [@wil12061164](/creator/x/wil12061164) on [X](/post/tweet/1946220424859361338) 2025-07-18 14:48:02 UTC 3765 followers, XX engagements "#Stock 🔥✅ REPORT $JNJ Johnson & Johnson ✅🔥 #EARNINGS 👉 EPS: $XXXX / $XXXX (expected) 👉 Revenue: $23.74B / $22.86B (expected) $JNJ: +0.67%" [@Teplitsa_](/creator/x/Teplitsa_) on [X](/post/tweet/1945716551828512991) 2025-07-17 05:25:50 UTC XXX followers, XX engagements "$AMD up XXXX% - Jefferies & Co increased price target from $XXX to $XXX. $BAC increase price targets from $XXX to $XXX $JNJ up XXXX% after double beat on earnings; Revenue up XXX% YoY and raising its full-year guidance EPS: $XXXX vs $XXXX Revenue: $23.74B vs $22.86B 4/9" [@EtCrypto20](/creator/x/EtCrypto20) on [X](/post/tweet/1945698076196589888) 2025-07-17 04:12:25 UTC XX followers, XX engagements "$JNJ announces its Q2 2025 earnings: EPS at $XXXX beating estimates by $XXXX with revenue at $23.74B (+5.77% YoY). Notably XX brands reported double-digit growth despite challenges from STELARA's biosimilar competition. 🚀 Key highlights in growth (4.6%) across diverse sectors especially Innovative Medicine and MedTech. Future prospects look solid with important product launches ahead. 📈 However watch for risks related to market competition and increased debt from acquisitions. For more details check" [@value_verge](/creator/x/value_verge) on [X](/post/tweet/1945690564814586038) 2025-07-17 03:42:34 UTC XX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Johnson & Johnson (JNJ) shares are up after a strong Q2 earnings report, beating estimates and raising the company's outlook for the year. The stock is up X% after Q2 results beat estimates.
This topic is about the financial performance and social media discussion surrounding Johnson & Johnson (JNJ) stock.
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXX
6 Months: XXXXXX +7,632%
1 Year: XXXXXX -XX%
1-Year High: XXXXXX on 2025-07-16
1-Year Low: X on 2024-10-22
Social Network | X |
---|---|
Engagements | XXX |
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: X
6 Months: XX +313%
1 Year: XX +273%
1-Year High: XX on 2025-07-17
1-Year Low: X on 2024-10-05
Social Network | X |
---|---|
Mentions | XX |
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $2374b in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: X
6 Months: XX +314%
1 Year: XX +260%
1-Year High: XX on 2025-07-17
1-Year Low: X on 2024-10-05
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XXX%
1 Year: XXX% +93%
1-Year High: XXX% on 2025-07-16
1-Year Low: XXX% on 2025-07-16
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXX | XX% | XXX | XX% | X | X% |
Total | XXX | XX% | XXX | XX% | X | X% |
Top assets mentioned In the posts about $2374b in the last XX hours
Johnson & Johnson (JNJ) Johnson & Johnson (JNJ) Innovative Solutions & Support (ISSC) Basis Cash (BAC) Bank of America (BAC) GammaSwap (GS) Morgan Stanley (MS) Morgan Stanley (MS) Goldman Sachs (GS) Ventas, Inc. (VTR)
Top topics mentioned In the posts about $2374b in the last XX hours
eps, jnj, $jnj, johnson johnson, stocks healthcare, $2286b, rev, $932b, medtech, $936b, $2285b, $913b, $issc, $2284b, stocks, $554b, $2283b, $914b, $934b, med, $354b, $bac, bank of america, stocks financial services, stocks banks, del, $62b, $931b, $927b, quarterly earnings, cmg, $338b, $181b, $165b, $1350b, $1458b, $gs, $1591b, $168b, $ms, $2659b, $265b, united states, bank of, $2280b, notable, morgan stanley, goldman sachs, wallstreet, new york stock exchange, investment, $vtr, stocks real estate, coins ai, dru, cash flow, $918b, $91b, open ai, $amd, athens, advanced micro devices, stocks technology, coins defi, bmnr, founders fund, bitmine, stocks bitcoin treasuries, stocks crypto treasuries, $bmnr, stockmarket, $85b, sales forecast, $838b, $1846b, $1555b, bitfinex, $4141b, $2549b, $2394b, $3157b, $2195b, bitcoin, coins layer 1, coins bitcoin ecosystem, coins pow, $fbtc, stocks etf, stocks bitcoin spot etf, stocks crypto etfs, ticker, tax bracket
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Grayscale (Grayscale Bitcoin Trust): $21.95B$31.57B (183349263801 BTC) U.S. Government: $23.94B$25.49B (200000213000 BTC) Fidelity (FBTC): $23.74B$41.41B (198424346000 BTC) Bitfinex: $15.55B$18.46B (130010154246 BTC) Winklevoss Twins: $8.38B (70000 BTC)"
@wil12061164 on X 2025-07-18 14:48:02 UTC 3765 followers, XX engagements
"#Stock 🔥✅ REPORT $JNJ Johnson & Johnson ✅🔥 #EARNINGS 👉 EPS: $XXXX / $XXXX (expected) 👉 Revenue: $23.74B / $22.86B (expected) $JNJ: +0.67%"
@Teplitsa_ on X 2025-07-17 05:25:50 UTC XXX followers, XX engagements
"$AMD up XXXX% - Jefferies & Co increased price target from $XXX to $XXX. $BAC increase price targets from $XXX to $XXX $JNJ up XXXX% after double beat on earnings; Revenue up XXX% YoY and raising its full-year guidance EPS: $XXXX vs $XXXX Revenue: $23.74B vs $22.86B 4/9"
@EtCrypto20 on X 2025-07-17 04:12:25 UTC XX followers, XX engagements
"$JNJ announces its Q2 2025 earnings: EPS at $XXXX beating estimates by $XXXX with revenue at $23.74B (+5.77% YoY). Notably XX brands reported double-digit growth despite challenges from STELARA's biosimilar competition. 🚀 Key highlights in growth (4.6%) across diverse sectors especially Innovative Medicine and MedTech. Future prospects look solid with important product launches ahead. 📈 However watch for risks related to market competition and increased debt from acquisitions. For more details check"
@value_verge on X 2025-07-17 03:42:34 UTC XX followers, XX engagements
/topic/$2374b